Blog - Page 308 of 5681 - QualityStocks

TuesdayJun 17, 2025 10:30 am

Newton Golf Company Inc. (NASDAQ: NWTG) Unveils Lighter Shaft amid Women’s Golf Boom

Women make up roughly 28% of on-course golfers in the United States, a historic high. The global golf equipment market is booming, generating an estimated $25.5 billion in 2024 and projected to grow at nearly 6% annually. Newton Golf’s lighter shaft is engineered to weigh less than previous versions while maintaining precision, stability and distance. A surge in women’s golf participation is reshaping the industry, drawing fresh energy and opportunity to equipment manufacturers. Newton Golf Company (NASDAQ: NWTG) recently released the perfect piece of equipment for this dynamic market — a lighter shaft option, designed to deliver premium performance for golfers…

TuesdayJun 17, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet’s Disease

Behçet’s disease is more prevalent in countries along the Silk Road, including Türkiye, Iran and Japan. Even with treatment, symptoms can continue occurring for many patients and significantly affect their quality of life and productivity. Soligenix has initiated a clinical trial to evaluate the safety, tolerability and preliminary efficacy of SGX945 in patients suffering from oral ulcers. Behçet’s disease is a rare, chronic autoimmune disorder characterized by inflammation of blood vessels, leading to a range of symptoms including painful mouth and genital ulcers, eye inflammation and skin lesions. With limited treatment options available, Soligenix (NASDAQ: SNGX) is at the forefront of…

TuesdayJun 17, 2025 9:10 am

QualityStocksNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast

Intelligent Bio Solutions (NASDAQ: INBS) CEO Harry Simeonidis joined the latest episode of The BioMedWire Podcast to discuss the company’s rapid, non-invasive drug screening platform and global expansion strategy. Simeonidis detailed how the company’s fingerprint-based technology detects drug use through sweat, enabling faster and more affordable workplace screening. With current deployments in about 20 countries and an FDA application under review, Intelligent Bio Solutions is targeting U.S. market entry in the second half of 2025 and expects to scale through distributor partnerships and targeted marketing. To view the full article, visit https://ibn.fm/HZpfg About Intelligent Bio Solutions Inc. Intelligent Bio Solutions…

TuesdayJun 17, 2025 9:00 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Is ‘One to Watch’

LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million. The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces. Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt. LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports…

TuesdayJun 17, 2025 9:00 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring

HeartBeam to integrate AccurECG(TM), AccurKardia’s FDA-cleared ECG analysis software Collaboration enhances HeartBeam’s commercial offering with automated arrhythmia insights Combined platform aims to improve cardiac care access and speed time to diagnosis HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with AccurKardia, a leader in automated ECG diagnostics, to integrate its FDA-cleared AccurECG(TM) software into HeartBeam’s cable-free, credit card-sized 3D ECG device. The partnership unites two innovators in ambulatory cardiac monitoring to create a more scalable, accessible solution for arrhythmia detection and management. HeartBeam’s device captures electrical signals in three non-coplanar directions and synthesizes them into a 12-lead ECG for remote use.…

MondayJun 16, 2025 12:45 pm

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Poised to Capitalize on Rising Platinum, Palladium Prices Amid Renewed Demand

Platinum prices have recently reached their highest levels in more than two years. Palladium has also seen renewed interest as industrial demand stabilizes and inflation pressures persist. Platinum Group Metals Ltd. stands out due to its advanced-stage project, strong partnerships and commitment to innovation. In recent weeks, platinum and palladium prices have gained considerable momentum, driven largely by a resurgence in demand from China’s jewelry sector and increasing concern over global supply constraints. Platinum Group Metals (NYSE American: PLG) (TSX: PTM), a development-stage mining company focused exclusively on platinum group metals (“PGMs”), is well positioned to capitalize on these favorable…

MondayJun 16, 2025 12:00 pm

HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’

HeartBeam has developed the first cable-free system capable of synthesizing a 12-lead ECG from 3D, non-coplanar electrical signals captured in real time. Patients can have the HeartBeam System with them at all times, ready to record an ECG in 30 seconds at home or anywhere when they feel symptoms to reduce delays in care. The HeartBeam System is now FDA cleared for arrhythmia assessment, with additional FDA review underway for its 12-lead ECG synthesis software for the same indication. A recent partnership with AccurKardia enhances HeartBeam’s arrhythmia solution with an FDA-cleared automated rhythm interpretation software. HeartBeam holds 20 issued patents,…

MondayJun 16, 2025 9:20 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its subsidiary HOPE Therapeutics announced a strategic investor relations partnership with astr partners, a boutique firm specializing in life sciences. The collaboration comes as NRx advances toward two NDA filings, an ANDA submission, and expands its interventional psychiatry clinic acquisitions. Led by veterans of The Trout Group, astr will support NRx and HOPE with investor targeting, message development, earnings prep, and institutional outreach to enhance visibility and engagement. To view the full press release, visit https://ibn.fm/6WIj9 About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on…

MondayJun 16, 2025 9:00 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG

HeartBeam’s credit card-sized device demonstrated 93.4% diagnostic agreement with standard ECGs VALID-ECG study results presented at Heart Rhythm Society conference Company eyes U.S. commercialization pending FDA clearance HeartBeam (NASDAQ: BEAT) announced its synthesized 12-lead ECG met clinical endpoints in the VALID-ECG pivotal study, achieving 93.4% diagnostic agreement with standard ECGs for arrhythmia assessment. The findings, presented by Dr. Thomas Deering of Piedmont Heart Institute at the Heart Rhythm Society’s annual meeting in San Diego, validate HeartBeam’s compact, patient-friendly ECG technology. The study compared ECG intervals and amplitudes between HeartBeam’s synthesized output and simultaneously collected standard ECGs in 198 patients across…

FridayJun 13, 2025 3:48 pm

QualityStocksNewsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Forest Hill Rd Project Adds to Growing Development Pipeline

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) was featured in a recent article that discussed its momentum with the development of its Forest Hill Rd solar project in upstate New York. “The 4.584 megawatt DC installation will operate as a community solar facility, contributing renewable energy to the local grid and offering cost savings to approximately 540 homes,” reads the article. “The project adds to SolarBank’s growing development pipeline, which now exceeds one gigawatt and already includes several solar projects in upstate New York. It also represents continued expansion in the U.S. market at…

Site Search

Company Search